GMAB:NASDAQ
Genmab A/S - ADR
34,52 $
arrow_downward
-0,07%(-0,025) 1D
2 հոկ, 14:32:52 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
34,39 $
High
35,02 $
Low
33,72 $
Mkt. cap
21,88 մլրդ
Avg. vol.
2,58 մլն
Volume
3,38 մլն
P/E ratio
27,20
52-wk high
35,90 $
52-wk low
23,62 $
EPS
1,27 $
Beta
0,81
Shares outstanding
624,06 մլն
No. of employees
3 հզր
Open
34,39 $
High
35,02 $
Low
33,72 $
Mkt. cap
21,88 մլրդ
Avg. vol.
2,58 մլն
Volume
3,38 մլն
P/E ratio
27,20
52-wk high
35,90 $
52-wk low
23,62 $
EPS
1,27 $
Beta
0,81
Shares outstanding
624,06 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
TipRanks
·
21 րոպե առաջ
Genmab Discloses Darwin Global as 5.11% Major Shareholder
Stock Titan
·
55 րոպե առաջ
One investment manager controls votes on 3.19 million Genmab (GMAB) shares.
Yahoo! Finance Canada
·
57 րոպե առաջ
Major Shareholder Announcement
AD HOC NEWS
·
5 ժամ առաջ
Genmab outlines three Phase 3 readouts and Genmab stock costs EUR 306.70
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees3,12 հզր
Founded11 հնս, 1998 թ.
Headquarters-
Sector-
Websitegenmab.com